Subclinical persistence of residual acral melanoma in situ after treatment with topical imiquimod and retinoid creams
Main Authors: | Jenne P. Ingrassia, BA, Elizabeth Greenwald, MD, Shane Meehan, MD, Jennifer A. Stein, MD, PhD, Tracey N. Liebman, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-03-01
|
Series: | JAAD Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352512624000043 |
Similar Items
-
Imiquimod cream improves photodamaged skin
by: Suliman S Alfaraj, et al.
Published: (2022-01-01) -
Imiquimod 5% Cream for Treatment of Actinic Keratosis of the Eyelid
by: Gamze Ozturk Karabulut, et al.
Published: (2017-05-01) -
Treatment of cutaneous tumors with topical 5% imiquimod cream
by: Sabrina Sisto Alessi, et al.
Published: (2009-01-01) -
Topical imiquimod in combination with brachytherapy for unresectable cutaneous melanoma scalp metastases
by: Jennifer E. Yeh, MD, PhD, et al.
Published: (2023-01-01) -
Superficial basal cell carcinoma treated with curettage followed by topical imiquimod cream: A retrospective study
by: Andrew L. Ondo, MD, et al.
Published: (2024-03-01)